Adma Biologics, Inc.(ADMA)Earnings Date, History & Expected Move

Next report
Not scheduled

ADMA has no upcoming report date in the calendar yet. It last reported on Nov 4, 2026; companies usually report every three months.

Next report
Not scheduled
Last reported Nov 4, 2026
EPS beat rate
55%
6 of 11 quarters (+1 not counted)
Avg move after earnings
±13.6%
Up 50% of the time · last 12
Options-implied move
—
No reliable options quote yet

EPS: Actual vs Estimate

Reported EPS against the consensus estimate, last 12 quarters.

Green beat or met, red missed, amber sources differ.

Stock Reaction After Earnings

Close-to-close move in the first session that reflected each report.

Dashed lines mark the average actual move (±13.6%).

Did the stock rise after good news?

The next-day move after each of its last 6 EPS beats and 3 misses.

When it beat expectations
6 reports
When it missed expectations
3 reports

In plain words: it beat expectations 6 times, but the stock still fell 2 of those 6 times.

Report by report
  • Nov '26
    Beat
    ▲ +26.0%
  • May '26
    Missed
    ▼ -16.0%
  • Feb '26
    Beat
    ▼ -3.2%
  • May '25
    Missed
    ▼ -10.2%
  • Mar '25
    Missed
    ▲ +7.5%
  • Nov '24
    Beat
    ▲ +14.7%
  • Aug '24
    Beat
    ▲ +30.9%
  • May '24
    Beat
    ▲ +27.1%
  • Feb '24
    Beat
    ▼ -0.4%

Clear beats and misses with a known reaction only. What counts as a beat

After an EPS beat
+15.9%
average next-day move · up 67% of 6 times
After an EPS miss
-6.2%
average next-day move · up 33% of 3 times

Why did ADMA fall after beating earnings?

3 of ADMA's last 9 reactions went against the EPS result. What stands out in each:

ADMA beat EPS estimates in 6 quarters, and the stock still closed lower the next day 2 times.

  • Feb 25, 2026EPS beat +10.0%stock -3.2% next day
    • It opened 3.6% higher, but sellers took over and it closed -3.2%.
  • Feb 28, 2024EPS beat +100.0%stock -0.4% next day
    • It had risen 3.9% in the final week before the report, so good news may already have been priced in.

Rose despite an EPS miss (1 of 3)

  • Mar 3, 2025EPS missed -6.7%stock +7.5% next day

    Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.

Patterns in estimates and prices, not confirmed causes: how we read them.

Was ADMA's earnings move already priced in?

ADMA's move in the month before each of its last 12 reports, against what it did after.

Avg move in the month before
+5.4%
last 12 reports
Higher before the report
75%
of the time
After a run-up of 3%+
Fell 40%
5 reports, avg +9.8%

How the run-up is measured (a move of 5% or more counts as large).

Before vs after each report

Grey: the month before each of the last 12 reports. Green or red: the day after.

Past reports only. How the run-up is measured

Does ADMA hold its opening gap after earnings?

ADMA's opening move after each report and where it closed that day.

In 11 reports ADMA opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 11 times (18%), and fully reversed 2 times. Gaps up faded 1 of 6; gaps down recovered 1 of 5.

  • Nov 4, 2026Held
    Opened +14.6%, closed +26.0%
  • Aug 5, 2026Held
    Opened +4.8%, closed +8.6%
  • May 6, 2026Held
    Opened -25.3%, closed -16.0%
  • Feb 25, 2026Reversed
    Opened +3.6%, closed -3.2%
  • Nov 5, 2025Held
    Opened -3.1%, closed -8.7%
  • Aug 6, 2025Held
    Opened -14.5%, closed -9.7%
  • May 7, 2025Held
    Opened -3.7%, closed -10.2%
  • Mar 3, 2025Reversed
    Opened -5.9%, closed +7.5%

How gaps, fades and reversals are defined

ADMA earnings history

Last 12 reported quarters with the stock's reaction.

Swipe sideways to see every column →

Report dateTimeEPS est.EPS actualSurpriseRevenue surprise1-day move3-day move
Nov 4, 2026After close$0.20$0.23+15.0%+0.1%+26.05%—
Aug 5, 2026After close$0.16$0.17sources differ—+8.64%+5.29%
May 6, 2026After close$0.20$0.17-15.0%—-15.97%-21.83%
Feb 25, 2026After close$0.20$0.22+10.0%—-3.19%+5.74%
Nov 5, 2025After close$0.16$0.160.0%—-8.72%-4.29%
Aug 6, 2025After close$0.14$0.140.0%—-9.65%-11.65%
May 7, 2025After close$0.17$0.11-35.3%—-10.21%-13.38%
Mar 3, 2025After close$0.15$0.14-6.7%—+7.45%+6.82%
Nov 7, 2024After close$0.13$0.15+15.4%—+14.71%+10.45%
Aug 8, 2024After close$0.08$0.13+62.5%—+30.93%+41.67%
May 9, 2024After close$0.05$0.08+60.0%—+27.13%+32.18%
Feb 28, 2024After close$0.02$0.04+100.0%—-0.37%+6.32%

ADMA Earnings FAQ

Answers computed from Adma Biologics, Inc.'s reported history

ADMA has no upcoming report date in the calendar yet. It last reported on Nov 4, 2026; companies usually report every three months.

Over the last 11 quarters with a usable EPS surprise, ADMA beat the consensus estimate 6 times (55%), missed 3 and landed in line 2. 1 quarter where our data sources disagree on beat versus miss are shown but not counted.

Across its last 12 quarters with a measured reaction, ADMA moved an average of ±13.6% in the first session after reporting. It closed higher 50% of the time; the largest gain was 30.9% and the largest drop -16.0%.

ADMA fell in the first session after 2 of its last 6 EPS beats (33%). A beat that was already priced in, or weaker guidance, can send a stock lower.

Across its last 12 quarters with price data, ADMA moved an average of +5.4% in the 20 trading sessions before reporting and was higher in 75% of them. After a run-up of 3% or more (5 quarters), it fell the next day 40% of the time, averaging +9.8%. This describes past reports; it is not a forecast.

In 11 reports ADMA opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 11 times (18%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.

How we calculate these numbers · ADMA: 12 reported quarters, latest Nov 4, 2026. Information only, not investment advice.

Looking for more on ADMA?

Price charts, forecast, fundamentals and risk pages for ADMA are not on Tickzen yet. You can run a full stock analysis now.

Run the ADMA Stock Analyzer